The world-wide neurostimulation market is catching the eye of many within the medtech, pharmaceutical, and investing industries. This is because of the accelerated growth in the U.S. and European markets and the over 100 million potential patients with chronic pain, Parkinson’s disease, epilepsy and many more indications that can be treated with neurostimulators.
Take a look at our roundup of insights on the neurostimulation market and learn what our experts are saying about this growing industry.
BI and DRG Analyst Briefing: An Analysis of the Increasingly Competitive Neurostimulation Market
Bloomberg Intelligence and DRG co-hosted a webinar discussion on the current and future breakdown of the overall neurostimulation market and its potential to impact the aforementioned industries.
Market Snapshot: Neurostimulation
DRG, in partnership with Bloomberg Intelligence, has delved into the competitive neurostimulation market, analyzing factors such as market share and hospital penetration by brand.
Neurostimulation Devices | Medtech 360 | Market Insights | United States
The US neurostimulation device market will grow rapidly due to the approval of new indications and technologies that will drive adoption of these devices through 2025. This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurostimulation devices in the US across a 10-year period.